Journals / Turkish Neurosurgery / 2017 / Cilt: 27 - Sayı: 5

Predictors for Recurrence of Chronic Subdural Hematoma

Pages
756–762
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, our data clearly emphasize the importance of surgically applied drainage implants to prevent a recurrence of cSDH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: This prospective study was designed to analyze the dependence of different factors on the recurrence rate of chronic subdural hematoma (cSDH) after surgical treatment.
📊
Key Findings & Data:MATERIAL and METHODS: Seventy-three consecutive patients, who were surgically treated at our department due to cSDH between 2009 and 2012, were included.
💡
Conclusion & Impact:Furthermore, our data clearly emphasize the importance of surgically applied drainage implants to prevent a recurrence of cSDH.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

AIM: This prospective study was designed to analyze the dependence of different factors on the recurrence rate of chronic subdural hematoma (cSDH) after surgical treatment. MATERIAL and METHODS: Seventy-three consecutive patients, who were surgically treated at our department due to cSDH between 2009 and 2012, were included. The following parameters were analyzed: patient age and gender, occurrence of trauma, time between trauma and admission, neurological symptoms, presence of minor diseases, intake of anticoagulation medication. We classified the results of diagnostic imaging and determined the space-consuming effect via the cerebral midline shift. In addition, we scrutinized intraoperative findings and the dependence of the position of subdural drainage on the recurrence rate of cSDH. RESULTS: In our patient group, cSDH recurrence was significantly associated with aphasia (p=0.008). Moreover an increased cSDH recurrence rate was observed in the patient group that had a separated manifestation of the cSDH in the preoperative diagnostic imaging (p=0.048) and received no drainage implant (p=0.016). Homogeneous isodense cSDH was associated with no apparent recurrence (p=0.037). CONCLUSION: Within the scope of this study, we detected aphasia and separated cSDH as predictors of cSDH recurrence. Homogeneous isodense cSDH seems to be a good prognostic sign regarding the risk of recurrence development. Furthermore, our data clearly emphasize the importance of surgically applied drainage implants to prevent a recurrence of cSDH.

🔖

Cite This Article

HAMMER, A., TREGUBOW, A., KERRY, G., SCHREY, M., HAMMER, C., STEINER, H. (2022). Predictors for Recurrence of Chronic Subdural Hematoma. Turkish Neurosurgery, Cilt: 27 - Sayı: 5, 756–762. https://ajindex.com/articles/616932

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abouzari M, Rashidi A, Rezaii J, Esfandiari Kh, Asadollahi M, Aleali H, Abdollahzadeh M: The role of postoperative patient posture in the recurrence of traumatic chronic hematoma after burr-hole surgery. Neurosurgery 61: 794-797, 2007 2. Althoff H, Krenkel W, Schroder J: Raumfordernde Hämatome der hinteren Schädelgrube. Beitr Gerichtl Med 40: 395-401, 1982 (In German) 3. Destandau J, Dartigues JF, Cohadon F: Chronic subdural hematoma in adult. Prognostic factors of surgery. Apropos of 100 cases. Neurosurgery 33(1): 17-22, 1987 4. Ernestus RI, Beldzinski P, Lanfermann H, Klug N: Chronic subdural hematoma: Surgical treatment and outcome in 104 patients. Surg Neurol 48: 220-225, 1997 5. Forster MT, Mathé AK, Senft C, Scharrer I, Seifert V, Gerlach R: The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 17(8): 975-979, 2010 6. Gonugunta V, Buxton N: Warfarin and chronic subdural haematomas. Br J Neurosurg 15: 514-517, 2001 7. Ito H, Yamamoto S, Komai T, Mizukoshi H: Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma. J Neurosurg 45: 26-31, 1976 8. Kang HL, Shin HS, Kim TH, Hwang YS, Park SK: Clinical analysis of recurrent chronic subdural hematoma. J Korean Neurosurg Soc 40: 262-266, 2006 9. Ko BS, Lee Jk, Seo BR, Moon SJ, Kim JH, Kim SH: Clinical analysis of risk factors to recurrent chronic subdural hematoma. J Korean Neurosurg Soc 42:11-15, 2008 10. Lind CR, Lind CJ, Mee EW: Reduction in the number of repeated operations for the treatment of subacute and chronic subdural hematomas by placement of subdural drains. J Neurosurg 99:44-46, 2003 11. Lindvall P, Koskinen LO: Anticoagulants and antiplatelets agents and the risk of development and recurrencs of chronic subdural haematomas. J Clin Neurosci 16(10):1287-1290, 2009 12. Markwalder TM: Chronic subdural hematomas: A review. J Neurosurg 54: 637-645, 1981 13. Markwalder TM, Seiler RW: Chronic subdural hematomas: To drain or not to drain? Neurosurgery 16: 185-188, 1985 14. Matsumoto K, Akagi K, Abekura M, Ryujin H, Ohkawa M, Iwasa N, Akiyama C: Recurrence factors for chronic subdural hematomas after burr-hole craniostomy and closed system drainage. Neurol Res 21: 277-280, 1999 15. Mellergard P, Wisten O: Operations and re-operations for chronic subdural haematomas during a 25-year period in a well defined population. Acta Neurochir 138: 708-713, 1996 16. Merlicco G, Pierangeli E, di Pad